Cargando…

Safety and tolerability of PD-1/PD-L1 inhibitors in elderly and frail patients with advanced malignancies

The number of elderly patients with cancer has increased due to aging of the population. However, safety of programmed cell death-1 (PD-1) or programed cell death ligand 1 (PD-L1) inhibitors in elderly patients remains controversial, and limited information exists in frail patients. The present stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakakida, Tomoki, Ishikawa, Takeshi, Uchino, Junji, Tabuchi, Yusuke, Komori, Satoshi, Asai, Jun, Arai, Akihito, Tsunezuka, Hiroaki, Kosuga, Toshiyuki, Konishi, Hirotaka, Hongo, Fumiya, Inoue, Masayoshi, Hirano, Shigeru, Ukimura, Osamu, Taguchi, Tetsuya, Takayama, Koichi, Itoh, Yoshito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406883/ https://www.ncbi.nlm.nih.gov/pubmed/32774487 http://dx.doi.org/10.3892/ol.2020.11875

Ejemplares similares

Predictors for development of denosumab-induced hypocalcaemia in cancer patients with bone metastases determined by ordered logistic regression analysis
por: Kanbayashi, Yuko, et al.
Publicado: (2021)

ANO9 regulates PD‐L2 expression and binding ability to PD‐1 in gastric cancer
por: Katsurahara, Keita, et al.
Publicado: (2021)

Association of Sarcopenia with and Efficacy of Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer
por: Nishioka, Naoya, et al.
Publicado: (2019)

Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of Japan
por: Sakakida, Tomoki, et al.
Publicado: (2023)

Intravascular Stapling Technique for Interlobar Fissure Division in the Left Lower Lobectomy
por: Tsunezuka, Hiroaki, et al.
Publicado: (2019)

Treatment impact of newly approved therapeutic agents for metastatic urothelial carcinoma in Japan: a single-center retrospective study
por: Inoue, Yuta, et al.
Publicado: (2023)

Double renal cell carcinoma with histological type of clear cell carcinoma and papillary carcinoma in the same kidney concurrently treated with robot‐assisted partial nephrectomy
por: Shimizu, Teruki, et al.
Publicado: (2021)

PD-1/PD-L1 blockade in cancer treatment: perspectives and issues
por: Hamanishi, Junzo, et al.
Publicado: (2016)

Clinical PD-1/PD-L1 Blockades in Combination Therapies for Lymphomas
por: Katsuya, Hiroo, et al.
Publicado: (2023)

Spatial Profiles of Intratumoral PD-1(+) Helper T Cells Predict Prognosis in Head and Neck Squamous Cell Carcinoma
por: Yoshimura, Kanako, et al.
Publicado: (2021)

Robot‐assisted laparoscopic partial nephrectomy for horseshoe kidney: A case report
por: Fujihara, Atsuko, et al.
Publicado: (2019)

Pazopanib after Nivolumab-Induced Tumor Lysis Syndrome in a Patient with Metastatic Clear-Cell Renal Cell Carcinoma
por: Narukawa, Tsukasa, et al.
Publicado: (2020)

Usefulness of bicarbonate Ringer's solution as perfusate during transurethral resection of the prostate
por: Hongo, Fumiya, et al.
Publicado: (2021)

Treatment rationale and design of the induction chemotherapy and adjuvant thoracic radiation in resectable N2-3A/3B non-small cell lung cancer (ICAT) study
por: Tsunezuka, Hiroaki, et al.
Publicado: (2019)

PD-1(+) regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
por: Kamada, Takahiro, et al.
Publicado: (2019)

Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
por: Bai, Jie, et al.
Publicado: (2017)

Molecular characterization of immunoinhibitory factors PD-1/PD-L1 in chickens infected with Marek’s disease virus
por: Matsuyama-Kato, Ayumi, et al.
Publicado: (2012)

Phase I study of cancer lesion-targeted microwave coagulation therapy for localized prostate cancer: A pilot clinical study protocol
por: Yamada, Yasuhiro, et al.
Publicado: (2019)

Impact of Pd Loading on CO(2) Reduction Performance over Pd/TiO(2) with H(2) and H(2)O
por: Nishimura, Akira, et al.
Publicado: (2020)

Exceptionally rapid response to pembrolizumab in a SMARCA4‐deficient thoracic sarcoma overexpressing PD‐L1: A case report
por: Takada, Kohichi, et al.
Publicado: (2019)

Proton Pump Inhibitors Enhance the Antitumor Effect of Chemotherapy for Esophageal Squamous Cell Carcinoma
por: Matsumura, Shinya, et al.
Publicado: (2022)

TTF-1 and c-MYC-defined Phenotypes of Large Cell Neuroendocrine Carcinoma and Delta-like Protein 3 Expression for Treatment Selection
por: Miyagawa-Hayashino, Aya, et al.
Publicado: (2021)

Noncanonical PD-1/PD-L1 Axis in Relation to the Efficacy of Anti-PD Therapy
por: Long, Yiru, et al.
Publicado: (2022)

Clinical significance of neutrophil-to-lymphocyte ratio as a predictor of lymph node metastasis in gastric cancer
por: Kosuga, Toshiyuki, et al.
Publicado: (2019)

Increased both PD–L1 and PD–L2 expressions on monocytes of patients with hepatocellular carcinoma was associated with a poor prognosis
por: Yasuoka, Hidetaka, et al.
Publicado: (2020)

Robot‐assisted laparoscopic pyeloplasty for ureteropelvic junction obstruction due to aberrant blood vessel with ipsilateral retrocaval ureter
por: Inoue, Yuta, et al.
Publicado: (2021)

A big data-based prediction model for prostate cancer incidence in Japanese men
por: Kato, Mineyuki, et al.
Publicado: (2023)

Basis of PD1/PD-L1 Therapies
por: Seliger, Barbara
Publicado: (2019)

Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
por: De Sousa Linhares, Annika, et al.
Publicado: (2019)

Tertiary lymphoid organs in the inflammatory myopathy associated with PD-1 inhibitors
por: Matsubara, Shiro, et al.
Publicado: (2019)

Treatment with broad-spectrum antibiotics upregulates Sglt1 and induces small intestinal villous hyperplasia in mice
por: Ota, Takayuki, et al.
Publicado: (2022)

Efficacy of the combination use of aprepitant and palonosetron for improving nausea in various moderately emetogenic chemotherapy regimens
por: Yoshida, Naohisa, et al.
Publicado: (2019)

Imaging of Dopamine in PD and Implications for Motor and Neuropsychiatric Manifestations of PD
por: de la Fuente-Fernández, Raúl
Publicado: (2013)

The Evolution of Pd(0)/Pd(II)-Catalyzed Aromatic Fluorination
por: Sather, Aaron C., et al.
Publicado: (2016)

PD-1/PD-L1 Inhibitors in Cervical Cancer
por: Liu, Yuncong, et al.
Publicado: (2019)

PD-L1/PD-1 Axis in Glioblastoma Multiforme
por: Litak, Jakub, et al.
Publicado: (2019)

A snapshot of the PD-1/PD-L1 pathway
por: Ghosh, Chinmoy, et al.
Publicado: (2021)

The PD-1:PD-L1 axis in Inflammatory Arthritis
por: Canavan, Mary, et al.
Publicado: (2021)

An update on immunotherapy with PD-1 and PD-L1 blockade
por: Koh, Sung Ae
Publicado: (2021)

Photoluminescence of PdS(2) and PdSe(2) quantum dots
por: Wang, Xinyu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1ertcorlk2erf3t25oc6rrb8u8